(VIANEWS) – AMSC (AMSC.OL), VOSS VEKSEL OGLAND (VVL.OL), SARTORIUS STED BIO (DIM.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AMSC (AMSC.OL)
1395% sales growth and 8.21% return on equity
AMSC ASA, through its subsidiaries, invests in maritime assets and companies in the United States. It operates one international subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was incorporated in 2005 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, AMSC has a trailing twelve months EPS of kr-1.78.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 39.6%, now sitting on 102.25M for the twelve trailing months.
Volume
Today’s last reported volume for AMSC is 73258 which is 37.43% below its average volume of 117089.
Sales Growth
AMSC’s sales growth is 1367.3% for the ongoing quarter and 1395% for the next.
Yearly Top and Bottom Value
AMSC’s stock is valued at kr31.60 at 22:20 EST, below its 52-week low of kr34.15.
More news about AMSC.
2. VOSS VEKSEL OGLAND (VVL.OL)
17.5% sales growth and 10.95% return on equity
Voss Veksel- og Landmandsbank ASA provides banking products and services to private individuals and companies in Norway. The company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. The company was founded in 1843 and is based in Voss, Norway.
Earnings Per Share
As for profitability, VOSS VEKSEL OGLAND has a trailing twelve months EPS of kr33.04.
PE Ratio
VOSS VEKSEL OGLAND has a trailing twelve months price to earnings ratio of 7.87. Meaning, the purchaser of the share is investing kr7.87 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.95%.
Sales Growth
VOSS VEKSEL OGLAND’s sales growth is 5% for the current quarter and 17.5% for the next.
Moving Average
VOSS VEKSEL OGLAND’s value is higher than its 50-day moving average of kr254.16 and way higher than its 200-day moving average of kr230.71.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 46.9% and 48.5%, respectively.
More news about VOSS VEKSEL OGLAND.
3. SARTORIUS STED BIO (DIM.PA)
12.2% sales growth and 8.15% return on equity
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.
Earnings Per Share
As for profitability, SARTORIUS STED BIO has a trailing twelve months EPS of €3.36.
PE Ratio
SARTORIUS STED BIO has a trailing twelve months price to earnings ratio of 78.66. Meaning, the purchaser of the share is investing €78.66 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.15%.
Volume
Today’s last reported volume for SARTORIUS STED BIO is 48852 which is 29.49% below its average volume of 69287.
More news about SARTORIUS STED BIO.
4. TECHNIP ENERGIES (TE.PA)
6.6% sales growth and 18.64% return on equity
Technip Energies N.V., together with its subsidiaries, operates as an engineering and technology company for the energy transition in Europe, Russia, the Asia Pacific, Africa, the Middle East, and the Americas. The company operates in two segments, Projects Delivery; and Technology, and Products and Services. It is involved in the engineering, procurement, construction management, commissioning, and transport and installation of various energy projects. The company also engages in the study, engineering, procurement, construction, and project management of various onshore and offshore facilities related to gas monetization, ethylene, hydrogen, refining, and chemical processing from biofuels and hydrocarbons. In addition, it develops, designs, commercializes, and integrates a range of technologies in gas monetization, refining, petrochemicals and fertilizers, hydrogen, and sustainable chemistry; provides land and marine-based loading and transfer systems services to the oil and gas, petrochemical, chemical, and decarbonization industries; and offers a range of project management consulting services to the energy industry. Further, the company offers robotics, visual intelligence, and surveillance solutions, as well NDT services; operations and maintenance consulting. Additionally, it provides Capture.Now, a set of decarbonization solutions; Canopy, an integrated suite of post-combustion carbon capture solutions; heat transfer technologies and products; INO15, a floating offshore wind solutions; SnapLNG, an electrified low-carbon LNG solution, as well as advisory and digital services. Technip Energies N.V. was incorporated in 2019 and is headquartered in Nanterre, France.
Earnings Per Share
As for profitability, TECHNIP ENERGIES has a trailing twelve months EPS of €1.64.
PE Ratio
TECHNIP ENERGIES has a trailing twelve months price to earnings ratio of 14.27. Meaning, the purchaser of the share is investing €14.27 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.64%.
More news about TECHNIP ENERGIES.
